Newer therapies for multiple conditions were major stories this year, but long-term HF survival gains seem to have vanished.

While genetics play a role in heart disease risk, lifestyle modifications can significantly influence outcomes. Individuals ...

Vitamin D is essential for bone health, mineral balance, and regulating parathyroid hormones. While sun exposure is the best source of vitamin D that supports bone strength and reduces health risks, ...

Most people know that the risk factors for heart disease are high blood pressure, smoking, raised cholesterol and being ...

Ziltivekimab is under clinical development by Novo Nordisk and currently in Phase III for Myocardial Infarction.

Entresto is under clinical development by Novartis and currently in Phase III for Left Ventricular Hypertrophy.

Eli Lilly and Novo Nordisk are likely to introduce its popular injectable drugs semaglutide and tirzepatide in India in 2025.

“The evidence suggests people lose, on average, around 20 minutes of life for each cigarette they smoke. The sooner a person ...

Uganda is facing a growing burden of NCDs, with currently 30 to 40 percent of deaths in health facilities across the country ...

The US Food and Drug Administration declined to approve the drug for people with type 1 diabetes and chronic kidney disease.

The top articles about pulmonary arterial hypertension (PAH) in 2024 included FDA approvals, the effect of salt substitutes ...

There are many different ways lifestyle diseases can be classified or grouped. Here is the way I like to group them: (1) ...